CVI Holdings’s Arcadia Biosciences RKDA Stock Holding History

CVI Holdings’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,377	Closed	-$414K	–	59
2019 Q2	$414K	Buy	+3,377	New	+$718K	0.48%	26
2018 Q3	–	Sell	-2,986	Closed	-$984K	–	52
2018 Q2	$984K	Buy	+2,986	New	+$1.63M	1.22%	17

Other funds holding RKDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAM

Blueshift Asset Management Red Bank, New Jersey $330M AUM 7.9% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CVI Holdings's RKDA Position: Q3 2019 in Review

CVI Holdings sold out of Arcadia Biosciences (RKDA) in Q3 2019, closing a stake of 3,377 shares — an estimated $414K sold.

CVI Holdings first reported a position in RKDA in Q2 2018 and held it in 2 quarters. The position peaked at $984K in Q2 2018. 18 funds tracked by Wall St. Rank hold RKDA as of Q3 2019.

CVI Holdings reported no remaining Arcadia Biosciences position as of Q3 2019 after selling out during the quarter.
CVI Holdings sold 3,377 Arcadia Biosciences shares in Q3 2019, an estimated $414K.
CVI Holdings first reported a position in Arcadia Biosciences in Q2 2018 and held it in 2 quarters.
CVI Holdings's Arcadia Biosciences position peaked at $984K in Q2 2018.
18 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q3 2019.

Based on CVI Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.